Not applicableLooking for participantsNCT07180056What this trial is testingAdjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast CancerWho this might be right forBreast Cancer Wenjin Yin 229
Not applicableStudy completedNCT02773784What this trial is testingComparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.Who this might be right forInvasive Breast Cancer Peking University 314
Large-scale testing (Phase 3)Study completedNCT01810393What this trial is testingAssess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 YearsWho this might be right forBreast Cancer Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT01042925What this trial is testingStudy of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based RegimenWho this might be right forBreast CancerBreast Neoplasms Sanofi 42
Not applicableActive Not RecruitingNCT07493291What this trial is testingEffectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer PatientsWho this might be right forBrest CancerCDK4/6 Inhibitor Al-Mustansiriyah University 100
Large-scale testing (Phase 3)Study completedNCT00600340What this trial is testing2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabWho this might be right forMetastatic Breast Cancer Central European Cooperative Oncology Group 564
Testing effectiveness (Phase 2)Active Not RecruitingNCT03587740What this trial is testingATOP TRIAL: T-DM1 in HER2 Positive Breast CancerWho this might be right forBreast Cancer Dana-Farber Cancer Institute 111
Early research (Phase 1)Looking for participantsNCT06251544What this trial is testingTRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerWho this might be right forBreast CancerTumor, BreastBreast Tumor+5 more Baylor College of Medicine 27
Large-scale testing (Phase 3)Study completedNCT03096847What this trial is testingStudy for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast CancerWho this might be right forAdvanced Metastatic Breast Cancer Novartis Pharmaceuticals 502
Large-scale testing (Phase 3)Study completedNCT00281658What this trial is testingStudy In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2Who this might be right forNeoplasms, Breast Novartis Pharmaceuticals 444
Not applicableStudy completedNCT05923268What this trial is testingMolecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted TherapyWho this might be right forBreast Cancer Female Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Study completedNCT02684032What this trial is testingAssess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerWho this might be right forBreast Cancer Celcuity Inc 141
Early research (Phase 1)UnknownNCT03487055What this trial is testingSafety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone MetastasesWho this might be right forBreast Cancer Jiangsu T-Mab Biopharma Co.,Ltd 30
Early research (Phase 1)Ended earlyNCT07408089What this trial is testingStudy of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast CancerWho this might be right forBreast CancerMetastatic Breast CancerAdvanced Breast Cancer Boundless Bio, Inc. 8
Not applicableNot Yet RecruitingNCT06449417What this trial is testingAurora: a Human-centered Program for Breast Cancer Patients in Chile, Easing Neoadjuvant Chemotherapy's EffectsWho this might be right forBreast Cancer Pontificia Universidad Catolica de Chile 30
Testing effectiveness (Phase 2)Looking for participantsNCT07612891What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid TumorWho this might be right forBreast Cancer (Locally Advanced or Metastatic)Advanced Solid CancersMetastatic (Stage IV) Breast Cancer+2 more Shenzhen Ionova Life Sciences Co., Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT06956690What this trial is testingA Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsWho this might be right forMelanoma (Skin)Non Small Cell Lung CancerBreast Cancer Hummingbird Bioscience 180
Very early researchStudy completedNCT04289532What this trial is testingIntegrin α6-targeted SPECT Imaging of Breast CancerWho this might be right forBreast Cancer Peking University 9
Early research (Phase 1)Active Not RecruitingNCT05809752What this trial is testingA First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)Who this might be right forLeptomeningeal DiseaseTriple Negative Breast CancerHER2-positive Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04842617What this trial is testingPhase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 NegativeWho this might be right forHormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer Jiangsu HengRui Medicine Co., Ltd. 5,274